Leveron&Nexovas
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1832  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
  »  Article in PDF (1,076 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  References
 »  Article Figures

 Article Access Statistics
    Viewed2868    
    Printed84    
    Emailed0    
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
LETTER TO EDITOR
Year : 2017  |  Volume : 65  |  Issue : 2  |  Page : 398-400

Anti-NMDAR encephalitis combined with a subependymoma


1 Department of Neurology, The Third Affiliated Hospital of Southern Medical University (Academy of Orthopedics-Guangdong Province); Department of Internal Medicine, Guangdong Women and Children Hospital, Guangdong, China
2 Department of Neurology, The Third Affiliated Hospital of Southern Medical University (Academy of Orthopedics-Guangdong Province), Guangdong, China
3 Department of Pathology, The Third Affiliated Hospital of Southern Medical University (Academy of Orthopedics-Guangdong Province), Guangdong, China

Date of Web Publication10-Mar-2017

Correspondence Address:
Dr. Tianming Lü
Department of Neurology, The Third Affiliated Hospital of Southern Medical University (Academy of Orthopedics-Guangdong Province), 183 Zhongshan Road West, Guangzhou, Guangdong - 510630
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/neuroindia.NI_1348_15

Rights and Permissions



How to cite this article:
Xiao D, Lin Y, Wang X, Yang C, Huang X, Fu B, Wei Q, Lü T. Anti-NMDAR encephalitis combined with a subependymoma. Neurol India 2017;65:398-400

How to cite this URL:
Xiao D, Lin Y, Wang X, Yang C, Huang X, Fu B, Wei Q, Lü T. Anti-NMDAR encephalitis combined with a subependymoma. Neurol India [serial online] 2017 [cited 2022 Dec 9];65:398-400. Available from: https://www.neurologyindia.com/text.asp?2017/65/2/398/201835


Sir,

Anti-N-methyl D-aspartate receptor (NMDAR) encephalitis is a novel NMDAR-mediated form of autoimmune encephalitis.[1] The main clinical manifestations include psychiatric symptoms, epilepsy, movement disorders, disturbance of consciousness, autonomic nervous system disorders, and central hypoventilation.[2] It is necessary to detect anti-NMDAR antibodies as early as possible to confirm the diagnosis of anti-NMDAR encephalitis.[2] Anti-NMDAR encephalitis is usually associated with a teratoma;[1] however, anti-NMDAR encephalitis combined with a subependymoma has still not been reported.

A 34-year-old male patient presented with neurological symptoms of blurred and magnified vision, paroxysmal amaurosis, and malaise. A heterogeneous space-occupying lesion was detected in the patient's right lateral ventricle, with slight hypointensity on T1 weighted imaging (WI), heterogeneous hyperintensity on T2-WI and T2-FLAIR imaging, without gadolinium contrast enhancement [Figure 1]. Anti-NMDAR antibodies were present in the cerebrospinal fluid (CSF), but not in the serum.
Figure 1: A heterogeneous space-occupying lesion was detected in the patient's right lateral ventricle on MRI. (a) Slight hypointensity on T1-WI. (b) Hyperintensity on T2-WI. (c) Slight hyperintensity on T2-flare. (d) No enhancement with gadolinium contrast on T1-WI

Click here to view


Six months after conservative treatment, the patient's symptoms had almost resolved. The mass was removed by surgical resection, and a series of histopathological examinations were performed. Hematoxylin and eosin staining showed that there were clusters of cellular neoplastic proliferation with islands of high nuclear density and abundant fibrillary matrices [Figure 2]a,[Figure 2]b,[Figure 2]c,[Figure 2]d. Immunofluorescence staining revealed that there were sporadic NMDAR-positive cells distributed in the glial fibrillary acidic protein (GFAP) positive cells and neuropil [Figure 2]e,[Figure 2]f,[Figure 2]g,[Figure 2]h. The tumor was histopathologically confirmed to be a subependymoma (WHO grade 1).
Figure 2: Histopathological observations. (a) Hematoxylin and eosin staining; (b) GFAP-positive cells; (c) S100-positive cells; (d) Immunopositive reaction; (e) NMDAR-positive cells; (f) GFAP-positive cells; (g) Nuclear staining with DAPI; (h) The merged image (e-g). (Bars = 50 μm)

Click here to view


The patient was, therefore, diagnosed as the first case of anti-NMDAR encephalitis associated subependymoma. Anti-NMDAR antibodies were detected in the CSF, but not in the serum, which strongly indicated that the anti-NMDAR antibodies were synthesized intrathecally. As the only intracranial neoplasm expressing immunogenicity to NMDAR in the central nervous system, the presence of a subependymoma may be closely related to the intrathecal composition of anti-NMDAR antibodies. Since the resection of subependymomas, the patient has not had a relapse at 1 year of follow-up observation.

A subependymoma is considered to be a variant or subtype of an ependymoma and may be originate from subependymal cells.[3] The cell of origin of a subependymoma is controversial and its ultrastructural features exhibit both astrocytic and ependymal differentiation.[3] The activated tumor cells of the subependymoma express functional NMDAR.[4] As the patient's immune allergens stimulate the body to produce anti-NMDAR antibodies, anti-NMDAR encephalitis may be induced.

This is the first reported case of anti-NMDAR encephalitis associated with a subependymoma, with NMDAR-positive immunoreactive cells and possible intrathecal anti-NMDAR antibody synthesis. The observations of this case would contribute towards ascertaining the mechanisms of anti-NMDAR encephalitis.

Financial support and sponsorship

National Natural Science Foundation of China (Grant No. 61072033); Natural Science Foundation of Guangdong Province (Grant No. 2014A030313273, 8151051501000053).

Conflicts of interest

There are no conflicts of interest.

 
 » References Top

1.
Scheer S, John RM. Anti-N-Methyl-D-Aspartate receptor encephalitis in children and adolescents. J Pediatr Health Care 2016;30:347-58.  Back to cited text no. 1
    
2.
Miya K, Takahashi Y, Mori H. Anti-NMDAR autoimmune encephalitis. Brain Dev 2014;36:645-52.  Back to cited text no. 2
    
3.
Prayson R, Cohen M. Subependymoma. Clifton: Humana Press 2000;2000:63-5.  Back to cited text no. 3
    
4.
Dave KA, Platel JC, Huang F, Tian D, Stamboulian-Platel S, Bordey A. Prostaglandin E2 induces glutamate release from subventricular zone astrocytes. Neuron Glia Biol 2010;6:201-7.  Back to cited text no. 4
    


    Figures

  [Figure 1], [Figure 2]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow